Résultats: 2

    AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals

    Gastroenterology; 168 (2), 2025
    Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managi...

    Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection

    Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease. The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expanded e...